|
|
European Blood Banking Devices MarketsPublished by: Frost & Sullivan Published: Mar. 10, 2008 - 96 Pages Table of Contents
AbstractThis Frost & Sullivan research service titled European Blood Banking Devices Markets provides an overview of blood banking devices that are currently in use within Europe, together with their revenues at a total European level, country level and segment level. The research provides a complete analysis of key challenges, drivers, restraints and trends in the market. Finally, it provides strategic solutions to enable vendors to overcome pricing issues within this market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: manual blood collection devices, apheresis devices and disposables and autologous devices and disposables.Technological Advances to Drive the Well-established European Blood Banking Devices Market The blood banking devices market in Europe will undergo profound transformation and experience higher growth rates in the future. "In order to respond to the growing concerns related to health and safety issues of blood and blood-derived products, the blood banking devices market is continuously launching innovative technology," notes the analyst of this research. "The transition from manual to automated devices is poised to transform the entire landscape and growth pattern of the blood banking devices industry." Product development continues in the manual blood collection devices segment, despite its steady decline. Thus, strong technological progress is anticipated even within this declining segment. This phenomenon can be explained by the fact that blood bags and their integrated accessories are set to dominate the market for the next ten years. It still represents the main revenue stream, therefore, for many companies. Simultaneously, promising research is occurring in the automated segments. Apheresis and automated whole blood processing devices are poised to replace their manual counterparts over time. In order to secure future competitiveness, significant investments are being made to develop such devices. These devices will help overcome issues such as shortfall of blood supply and increasing regulatory scrutiny. Due to these advantages, apheresis will gradually gain popularity. Automated whole blood processing devices represent a technological innovation and a revenue driver for the whole blood/donor side of the market. Some trends such as surgical advances suggest a decline in the autologous devices segment. However, an ageing population is resulting in increased surgical operations, leading to the further development and growth of this segment. Market Segments in Different Stages of Development Blood bags and their integrated accessories has been the most prolific segment for many years. Their widespread usage of around 65 per cent is due to their instructional simplicity and need for limited donor time commitment. Besides, the unit price is also less intensive. Automated devices such as apheresis, and the autologous technology, are based on a hardware piece, in conjunction with disposables. Apheresis devices only collect the necessary blood components while returning other parts to the donor, thus increasing the efficiency of each donor. Higher yield, enhanced blood safety as well as quality underline the appeal of automated devices. Autologous devices are used to collect and reinfuse the patients’ own blood before (pre-operation), during (intra-operation) or after (post-operation) a surgical procedure. The most commonly used autologous methods are intra- and post-operational procedures. Apheresis devices are used for pre-operational use only. Automated autologous devices are similar to apheresis technology in that they consist of a hardware piece and disposables. In the past few years, this segment has achieved stability without high price competition. "All the three segments in the market are going through different developmental phases," states the analyst. "Since the demand for blood and blood-derived products is likely to be maintained for some time, the problem of shortfalls in blood supply will be compensated and the blood banking devices market in Europe will benefit from this trend." Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||